A1 adenosine receptor agonists:: Medicinal chemistry and therapeutic potential

被引：29

作者：

Hutchinson, SA

Scammells, PJ

机构：

[1] Monash Univ, Victorian Coll Pharm, Dept Med Chem, Parkville, Vic 3052, Australia

[2] CSIRO, Div Text & Fibre Technol, Belmont, Vic 3216, Australia

来源：

CURRENT PHARMACEUTICAL DESIGN | 2004年 / 10卷 / 17期

关键词：

D O I：

10.2174/1381612043384204

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Adenosine receptors are widely distributed in the body and modulate numerous physiological processes. Four receptor Subtypes (termed A(1), A(2), A(2B) and A(3)) have been identified based on their pharmacological profile and cloning. Activation of the A(1) adenosine receptors produces a number of effects including a reduction in heart rate and atrial contractility, the attenuation of the stimulatory actions of catecholamines on the heart as well as a reduction of lipolysis in adipose tissue. As a result, A(1)AR agonists have been targeted as anti-arrhythmic and cardioprotective agents. This review discusses the synthesis, structure-activity relationships and therapeutic potential of A(1)AR agonists.

引用

收藏

页码：2021 / 2039

页数：19

相关论文

共 139 条

[1] THE ANTIHYPERTENSIVE EFFECT OF 2-ALKYNYLADENOSINES AND THEIR SELECTIVE AFFINITY FOR ADENOSINE A2-RECEPTORS [J].

ABIRU, T ;

YAMAGUCHI, T ;

WATANABE, Y ;

KOGI, K ;

AIHARA, K ;

MATSUDA, A .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 196 (01) :69-76

[2] A novel and facile reaction to N6-alkylated adenosine via benzotriazole as a synthetic auxiliary [J].

Afify, HMNM ;

Pedersen, EB ;

Zahran, MA .

JOURNAL OF HETEROCYCLIC CHEMISTRY, 2000, 37 (02) :339-341

[3] STUDIES ON THE PREPARATION, ISOLATION, AND REACTIONS OF ADENOSINE SCHIFF-BASES [J].

BADGER, EW ;

SZOTEK, DS ;

MOOS, WH .

NUCLEOSIDES & NUCLEOTIDES, 1986, 5 (02) :201-212

[4] Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: A possible template for adenosine receptor subtypes? [J].

Baraldi, PG ;

Cacciari, B ;

Borea, PA ;

Varani, K ;

Pastorin, G ;

Da Ros, T ;

Tabrizi, MA ;

Fruttarolo, F ;

Spalluto, G .

CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (26) :2299-2332

[5] Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5′-N-ethyluronamide as A1 and A3 adenosine receptor agonists [J].

Baraldi, PG ;

Cacciari, B ;

de Las Infantas, MJP ;

Romagnoli, R ;

Spalluto, G ;

Volpini, R ;

Costanzi, S ;

Vittori, S ;

Cristalli, G ;

Melman, N ;

Park, KS ;

Ji, XD ;

Jacobson, KA .

JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3174-3185

[6] IONIC BASIS OF THE ELECTROPHYSIOLOGICAL ACTIONS OF ADENOSINE CARDIOMYOCYTES [J].

BELARDINELLI, L ;

SHRYOCK, JC ;

SONG, Y ;

WANG, D ;

SRINIVAS, M .

FASEB JOURNAL, 1995, 9 (05) :359-365

[7]

BELARDINELLI L, 1987, TOPICS PERSPECTIVES, P344

[8]

BELARDINELLI L, 2001, Patent No. 0140799

[9] ROLE OF 5'-HYDROXYL GROUP OF ADENOSINE IN DETERMINING SUBSTRATE SPECIFICITY FOR ADENOSINE DEAMINASE [J].

BLOCH, A ;

ROBINS, MJ ;

MCCARTHY, JR .

JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (05) :908-&

[10] The synthesis and biological activity of a highly selective adenosine A2a receptor agonist [J].

Borcherding, DR ;

Lentz, NL ;

Weintraub, PM ;

Dudley, MW ;

Secrest, R ;

Kastner, PR ;

Peet, NP .

NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (10) :2175-2191

← 1 2 3 4 5 6 7 8 9 10 →